Subscribe: SCIENCE AND SOCIETY Podcasts
Added By: Feedage Forager Feedage Grade B rated
Language: English
american  chemistry  director  national  new  physics  professor  research  science technology  science  technology  university 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics


SCIENCE AND SOCIETY -- -- Conversations on medical breakthroughs, energy and the environment, nanotechnology, space exploration, planetary science, and K-12 science education. Each week, SCIENCE AND SOCIETY presents interviews wi

Published: 2008-01-14T10:19:17-08:00


Dr. James M. Gentile, President, Research Corporation, 1-14-08


Dr. James M. Gentile is president of Research Corporation, America’s second-oldest foundation and a major proponent of the advancement of science. He is a leader in the field of science education and a frequent speaker on issues involving the integration of scientific research and higher education. Dr. Gentile is a geneticist. Before joining Research Corporation he focused his research on the role of metabolism in the conversion of natural and xenobiotic agents into mutagens and carcinogens. Among many other national and international awards, he has received the Alexander Hollaender Research Excellence Award from the Environmental Mutagen Society, and he has been named a fellow of the American Association for the Advancement of Science. He was also the editor-in-chief for the international research journal Mutation Research for more than a decade. Dr. Gentile is a national associate of the National Research Council (NRC), where he played a leadership role in the highly praised NRC publication Biology 2010: Transforming Undergraduate Education for Research Biologists. He currently serves as president for the International Association of Environmental Mutagen Societies and is a current member of the editorial boards of four international journals. Dr. Gentile came to the Research Corporation from higher education. He served as dean for the natural sciences at Hope College in Holland, MI, where he held an endowed professorship. Over the years he has been a program director for grants from many public and private-sector institutions, including the National Institutes of Health, the National Science Foundation, the World Health Organization, and the Research Corporation. For nearly a century, Research Corporation, America’s first foundation for science advancement, has played a key role in creating the modern world and in improving our understanding of the universe. Among its accomplishments, which cover nearly all of the physical sciences, has been early support of research into rocket propulsion systems, atomic physics, nutritional diseases and astronomy. The foundation helped Robert Goddard, the father of modern rocketry; it funded the first large cyclotron; almost single-handedly wiped out pellagra and beriberi; and was instrumental in creating the field of radio astronomy. Vannevar Bush, who was instrumental in creating the National Science Foundation, was among the many distinguished scientists, engineers, academicians, business and policy experts who have served on the Research Corporation Board. In the years before World War II – when the benefits of science advancement became starkly apparent – and the subsequent chartering of the NSF in 1950, Research Corporation was the pioneering agency supporting organized research programs in the United States. More recently, anyone who has undergone magnetic resonance imaging has benefited from Research Corporation funding; and the foundation is currently helping to make possible the Large Synoptic Survey Telescope (LSST). In conjunction with Google and many academic partners, the LSST will deliver a continuing torrent of information about our changing universe to anyone with access to the Worldwide Web, beginning in a few years. Dr. James M. Gentile, current president of Research Corporation, says the foundation intends to continue supporting the best American science far into the future. “With every success, with each bit of knowledge gained, science becomes ever more complex, even as the problems facing a burgeoning humanity seem to grow more urgent,” Dr. Gentile adds. “In the face of our 21st century challenges – from global warming to energy scarcity, from genetic engineering to space exploration – Research Corporation will strive to be the ‘tip of the spear,’ opening new areas of study to benefit humankind.”[...]

Dr. Michael W. Deem, John W. Cox Professor in Biochemical and Genetic Engineering and Professor of Physics and Astronomy, Rice University, 1-14-08



Dr. Michael W. Deem is the John W. Cox Professor in Biochemical and Genetic Engineering and Professor of Physics and Astronomy at Rice University. His speciality is statistical mechanics, specifically the computer simulation of complex molecular systems. In many instances, the methods employed allow investigation of the increasingly tailored microscopic properties of material and biological systems. Moreover, new field-theoretic techniques in statistical mechanics allow computation of meso- and macroscopic material properties from such atomistic simulations. Professor Deem is interested in four main areas of research: bioinformatics, immune system response, protein structure and drug discovery, and zeolite structure and nucleation. His group uses both simulation and analytical statistical mechanics to attack these problems.

Professor Deem's many honors include the NSF CAREER Award (1997-2001); Northrop Grumman Outstanding Junior Faculty Research Award (1997); a Top 100 Young Innovator, MIT Technology Review (November 1999); Alfred P. Sloan Research Fellowship (2000); and the Camille Dreyfus Teacher-Scholar Award (2002).

Dr. Ping Sheng, Head of the Department of Physics and Director of the Institute of Nano Science and Technology, Hong Kong University of Science and Technology, 3-24-04



Dr. Ping Sheng is Head of the Department of Physics and, previously, Director of the Institute of Nano Science and Technology at the Hong Kong University of Science and Technology. He is also a Professor of Physics. Dr. Sheng is a Fellow of the American Physical Society, and Member of the Asia Pacific Academy of Materials. In 2002, he was awarded Technology Leader of the Year by the Sing Tao Group. Dr. Sheng has published over 200 papers and presented over 100 keynote or invited talks at international meetings and conferences. He also has 10 U.S. patents and is the author of a monograph on Wave Scattering, Localization, and Mesoscopic Phenomena.
Dr. Sheng's research is in the area of condensed matter physics. He has pioneered in the study of liquid crystal–substrate interaction while at the RCA David Sarnoff Research Laboratory, and established the mechanisms of charging-energy correlated hopping and fluctuation-induced tunneling conduction in disordered materials. While at Exxon Corporate Research Center from 1979-1994, Dr. Sheng's interest broadened into wave interaction and scattering in disordered systems, and porous media. The study of nanotechnology became his main focus after joining HKUST in 1994, where he led efforts in the discovery of superconducting behavior in ultrathin carbon nanotubes, and the giant electrorheological effect in suspensions of nanoparticles. Dr. Sheng is the inventor of locally resonant sonic materials that can break the mass density law in shielding low frequency sound.
The Institute of Nano Science and Technology (INST), established in 2001 with Dr. Sheng as the founding Director, is the first such research institute in Hong Kong. Its mission is to carry out fundamental research and innovation in nanoscience and technology. Besides the accomplishments in carbon nanotubes and electrorheological fluids, which were reported worldwide in the Washington Post, New Scientist, Science Now, Nanotechweb, and PhysicsWeb, INST achievements include the discovery of room temperature UV lasing from zinc oxide nanocrystals, the discovery of the giant Hall effect in granular metal films, and commercialization of the visible-blind UV detector based on semiconductor heterostructures.

Dr. Jun Wu, Co-founder and Chief Scientific Officer, Shanghai Genomics, 5-26-04



Shanghai Genomics, Inc., a leader of the Chinese biopharmaceutical industry, was founded and is managed by biotechnology professionals returning from the United States. Its mission is to develop novel therapeutic solutions for major diseases threatening the Chinese population, such as liver cirrhosis, acute lung injury/fibrosis, and infectious diseases. The first round of investors included two venture capital firms in China, Shanghai Venture Capital and Zhangjiang Hi-Tech Park Corporation. Shanghai Genomics is privately owned and headquartered at Zhangjiang Hi-Tech Park, Pudong New Area of Shanghai, China. The company has 67 employees and occupies a 30,000-square-foot facility. Shanghai Genomics provides contract research services and genomics/proteomics research tools and reagents to biotech/pharmaceutical companies worldwide. The services include antibody production, antibody screening and immunohistochemistry, recombinant protein production and purification, full-length gene cloning, and Q-PCR and PCR-based gene expression profiling.

Dr. Jun Wu is the co-founder of Shanghai Genomics Inc. He attended Shanghai Medical University as a medical student and later continued his undergraduate studies at San Jose State University in the United States. In 1991, he received his B.S. degree in Microbiology and Immunology. In 1997, he received his doctoral degree at University of California, San Francisco. Later, he joined DNAX Research Institute and Rigel Pharmaceuticals. Dr. Wu is an expert in lymphocyte signal transduction and tumor immunology.

Dr. Catherine T. Hunt, 2007 President, American Chemical Society, 8-9-07



Dr. Catherine T. (Katie) Hunt is the 2007 President of the American Chemical Society, the world's largest scientific society. She is also an employee of Rohm and Haas in Spring House, PA. She is Leader of Technology Partnerships (Emerging Technologies) for Rohm and Haas and her background is in catalysis and inorganic chemistry. In her 23 years in industry, Dr. Hunt has applied her background in these two areas across a broad range of electronics, materials, catalysis, hydrogen, coatings and health care.

Dr. Hunt received an A.B. degree in chemistry (cum laude with honors) in 1977 from Smith College in Massachusetts and a Ph.D. in chemistry from the University of California, Davis, in 1981. An ACS member since 1977, Dr. Hunt has been involved in numerous Society activities, including membership in the Philadelphia Local Section and the Divisions of Analytical Chemistry, Industrial and Engineering Chemistry and Inorganic Chemistry.

The American Chemical Society is a nonprofit organization, chartered by the U.S. Congress, with a multidisciplinary membership of more than 160,000 chemists and chemical engineers. ACS publishes numerous scientific journals and databases, convenes major research conferences and provides educational, science policy and career programs in chemistry. Its main offices are in Washington, D.C., and Columbus, OH.

ACS is a strong and successful advocate for the chemical sciences from education to legislation; an important hub of technical activities from meetings to publications and from divisions to websites; and a growing pool of resources from networks to workshops.

Dr. Eric Isaacs, Director, Center for Nanoscale Materials at Argonne National Laboratory, and Professor of Physics, James Franck Institute, University of Chicago, 8-9-07



Dr. Eric D. Isaacs is the Director of the Center for Nanoscale Materials at Argonne National Laboratory and Professor of Physics in the James Franck Institute at the University of Chicago. He received his Ph.D. from Massachusetts Institute of Technology in 1988 in the area of magnetic semiconductors and was a post-doc at Bell Laboratories (1988-1990) studying magnetism and superconductivity, mostly with synchrotron-based x-ray techniques. During his 13-year tenure at Bell Laboratories he was a Member of Technical Staff (1990-2000), Director of the Materials Physics Research Department (2000-2001), and Director of the Semiconductor Physics Department (2001-2003).

Dr. Isaacs has served on numerous national review and advisory committees including the APS Division of Materials Physics (2002-2005) and the DOE Basic Energy Sciences Advisory Committee (2002 - present). He is a fellow of the American Physical Society (2001).

Dr. Isaacs’s current research centers on studies of novel electronic and magnetic materials with a particular focus on creating images of new phenomena in reciprocal and real space at the nanoscale. Recent accomplishments include the direct observation of the cross-over to quantum dominated spin dynamics near a quantum critical point in the model magnetic system chromium. In order to achieve many of his results he has been a developer of modern synchrotron-based x-ray scattering techniques including inelastic x-ray scattering, x-ray photon correlation spectroscopy, and hard x-ray nano-probe.

The Center for Nanoscale Materials at Argonne National Laboratory is a national resource for the United States to foster new research capabilities in nanoscale synthesis and processing, and plays a key role in the U.S. Department of Energy’s participation in the interagency National Nanotechnology Initiative. The center’s mission includes supporting basic research and advanced instrumentation development for the creation of novel materials, using both top-down and bottom-up self-assembly, that provide new insights at the nanoscale level. The facility also supports a user program through peer-reviewed proposals that is open to academic, industrial, government, and international potential users.

Areas of expertise include Electronic and magnetic materials and devices

  • Nanobio interfaces

  • Nanofabrication

  • Nanophotonics

  • X-ray microscopy

  • Dr. Charis Eng, Chair and Founding Director, Genomic Medicine Institute, Cleveland Clinic Foundation, and Professor and Vice Chairman, Department of Genetics, Case Western Reserve University School of Medicine, 8-9-07



    Dr. Charis Eng is the Chair and founding Director of the Genomic Medicine Institute of the Cleveland Clinic Foundation, founding Director and attending clinical cancer geneticist of the institute’s clinical component, the Center for Personalized Genetic Healthcare, and Professor and Vice Chairman of the Department of Genetics at Case Western Reserve University School of Medicine.

    Dr. Eng holds a joint appointment as Professor of Molecular Medicine at the Cleveland Clinic Lerner College of Medicine and is a full member of Cleveland Clinic’s Taussig Cancer Center and a member of the CASE Comprehensive Cancer Center. She was recently honored by the designation National Scholar of the Davis Heart and Lung Research Institute of The Ohio State University, and continues to hold an honorary appointment at the University of Cambridge.

    Dr. Eng’s research interests may be broadly characterized as clinical cancer genetics translational research. Her work on RET testing in multiple endocrine neoplasia type 2 and the characterization of the widening clinical spectra of PTEN gene mutations have been acknowledged as the paradigm for the practice of clinical cancer genetics.

    Dr. Eng has published over 230 peer-reviewed original papers in such journals as the New England Journal of Medicine, JAMA, Lancet, Nature Genetics, Nature. She has received numerous awards and honors including election to the American Society of Clinical Investigation, to the Association of American Physicians and as Fellow of AAAS, the Doris Duke Distinguished Clinical Scientist Award and named a Local Legend from Ohio bestowed by the American Medical Women’s Association in conjunction with the U.S. Senate on women physicians who have demonstrated commitment, originality, innovation and/or creativity in their fields of medicine.

    Dr. Eng has been elected to a three-year term on the Board of Directors of the American Society of Human Genetics and will serve a four-year term on the Board of Scientific Directors of the National Human Genome Research Institute beginning in Autumn, 2007.

    Cathleen Campbell, President and CEO, U.S. Civilian Research and Development Foundation, 7-26-07



    U.S. Civilian Research & Development Foundation (CRDF) President and CEO Cathleen A. Campbell has nearly three decades of international science and technology policy and program management experience, serving most recently as CRDF's Senior Vice President.

    Ms. Campbell served from 1998 to 2002 as Director of the Office of International Policy and Programs in the Technology Administration of the Department of Commerce, as well as Executive Director of the U.S.-Israel Science and Technology Commission.

    From 1995 to 1997, she was a Senior Policy Analyst in the White House Office of Science and Technology Policy (OSTP) and for four months served as OSTP's Acting International Director. Ms. Campbell was the U.S. State Department's Program Officer for Soviet/Russian Science and Technology affairs, from 1989 to 1994, in which capacity she led an interagency team that developed and implemented new, post-Cold War policies and programs on science and technology cooperation with the former Soviet Union.

    The U.S. Civilian Research & Development Foundation (CRDF) promotes international science and technical collaborations. A private, nonprofit organization established in 1995 by the U.S. Government, CRDF has provided grants, technical assistance, and training to scientists and engineers in Eurasia for ten years. Recently, CRDF has expanded its geographical focus to include many areas beyond Eurasia, including the Middle East and Baltic regions.

    CRDF believes that the spirit of international science and technology cooperation provides critical benefits to the global community. CRDF supports foreign scientists and their U.S. counterparts in exceptional merit-reviewed research projects. These collaborations advance science and technical agendas of both American and foreign science. They also offer foreign scientists and engineers alternatives to emigration; help prevent the dissolution of their scientific and technological infrastructure; and advance the transition of weapons scientists to civilian work. CRDF also helps to move applied research to the marketplace by teaming U.S. companies with Eurasian scientists, and helps to strengthen research and education in universities abroad.

    Since 1995, CRDF has awarded nearly 3000 grants to 13,000 scientists—including 2,500 former weapons researchers—and has committed more than $102.8 million in total support.

    Dan Gerding, Managing Principal, Gerding Collaborative, 7-26-07



    Dan Gerding is Managing Principal of Gerding Collaborative (formerly Gerding Architects), an Atlanta-based firm he founded in 1993. The firm has a staff of nine and is located in Midtown Atlanta. Mr. Gerding received his Bachelor of Arts in Design from Clemson University, his Bachelor of Architecture from North Carolina State University, and has 23 years of professional experience. He has long held a keen interest in conservation and environmental responsibility - interests that have helped shape the direction of his firm and establish its goals for the future.

    Since 1993, Gerding Collaborative has provided creative design solutions resulting in projects of distinction. The Atlanta, GA-based firm seeks ecologically sensitive solutions that promote responsible use of energy, land and water resources for commercial, institutional and residential clients. More than 70% of the firm’s technical staff is LEED accredited.

    Craig Lund, Vice President, Chief Technology Officer, Mercury Computer Systems, 7-26-07



    Craig Lund coordinates the Mercury Computer Systems Technology Office, which is the company's lead lobbyist for strategic technology investments that anticipate the company's existing customer requirements as well as those that open new markets.

    Prior to joining Mercury, Mr. Lund was president of Local Knowledge, a technical consulting group he founded in 1991 to provide clients with technology-oriented market research and business planning services. Prior to Local Knowledge, Mr. Lund ran the engineering group at Mercury from 1986 to 1988. He also held engineering and marketing roles at Charles River Data Systems, the first company to create multicomputing computers using microprocessors.

    Mr. Lund was a key player in the design of the ANSI/VITA RACEway Interlink standard, one of the initial founders of the IEEE POSIX family of software standards, and is a member of the steering committee of the RapidIO Trade Association.

    Mercury Computer Systems is the leading provider of computing systems and software for data-intensive applications that include image processing, signal processing, and visualization. With a strong commitment to innovation, Mercury’s expertise in algorithm optimization, systems development, and silicon design is blended with software application knowledge and industry-standard technologies to solve unique computing challenges. Mercury works closely with customers to architect solutions that have a meaningful impact on everyday life - detecting aneurysms; designing safer, more fuel-efficient aircraft; identifying security threats; discovering oil; developing new drugs; and visualizing virtually every aspect of scientific investigation.

    Mercury’s comprehensive, purpose-built solutions capture, process, and present data for the world’s largest medical imaging companies, eight of the ten top defense prime contractors, and other leading Fortune 500 and mid-market companies in semiconductor, energy, telecommunications, and other industries. Mercury’s dedication to performance excellence and collaborative innovation continues a 24-year history in enabling customers to stay at the forefront of the markets they serve.

    Dr. Mark Wrighton, Chancellor, Washington University in St. Louis, 7-19-07


    Mark S. Wrighton, Ph.D., was elected the 14th Chancellor of Washington University in St. Louis in 1995, and serves as its chief executive officer. In the years following his appointment, the University has made significant progress in student quality, campus improvements, resource development, curriculum, and international reputation. Dr. Wrighton started his career at the Massachusetts Institute of Technology (MIT) in 1972 as Assistant Professor of Chemistry. He was appointed Associate Professor in 1976 and Professor in 1977. From 1981 until 1989 he held the Frederick G. Keyes Chair in Chemistry. In 1989 he was appointed the first holder of the Ciba-Geigy Chair in Chemistry. He was Head of the Department of Chemistry from 1987-1990 and became Provost of MIT in 1990, a post he held until the summer of 1995. Dr. Wrighton is the author or co-author of more than 300 articles published in professional and scholarly journals, and he holds 14 patents. He has research interests in the areas of transition metal catalysis, photochemistry, surface chemistry, molecular electronics, and in photoprocesses at electrodes. Principal objectives of his research have been to elucidate the basic principles underlying the conversion of solar energy to chemical fuels and electricity, to discern new catalysts and ways of making them, to understand chemistry at interfaces, and to provide the knowledge base for development of new electro-chemical devices. Dr. Wrighton has given more than 40 named lectureships at distinguished colleges and universities in the United States and other countries. Dr. Wrighton was awarded an Alfred P. Sloan Research Fellowship, 1974-1976, and was the recipient of a Dreyfus Teacher-Scholar Grant in 1975-1980. The American Chemical Society awarded him the Pure Chemistry Award in 1981 and the Award in Inorganic Chemistry in 1988. He was awarded a MacArthur Prize Fellowship in 1983. Also in 1983, he was awarded the Gregory and Freda Halpern Award in Photochemistry by the New York Academy of Sciences and the E. O. Lawrence Award by the United States Department of Energy. In 1984 he was selected as the recipient of the Fresenius Award of Phi Lambda Upsilon. Dr. Wrighton's teaching activities have been rewarded with the MIT Chemistry Department Graduate Teaching Award in 1981 and the MIT School of Science Teaching Prize in 1987. About 70 individuals have received the Ph.D. degree under his supervision at MIT. Dr. Wrighton was elected a Fellow of the American Academy of Arts and Sciences in 1988 and of the American Association for the Advancement of Science in 1986. Dr. Wrighton was a presidential appointee to the National Science Board (2000-06), which serves as science policy advisor to the President and Congress and is the primary advisory board to the National Science Foundation. Washington University, a medium-sized, independent university, is counted among the world’s leaders in teaching and research, and draws students and faculty to St. Louis from all 50 states and more than 120 nations. The University is highly regarded for its commitment to excellence in learning. Its programs, administration, facilities, resources, and activities combine to further its mission of teaching, research, and service to society. The University’s 59-acre Medical Campus includes the School of Medicine and the associated hospitals and institutes of the Washington University Medical Center. The University encompasses 2,221 acres and more than 150 major buildings. The University offers more than 90 programs and almost 1500 courses leading to bachelor’s, master’s, and doctoral degrees in a broad spectrum of traditional and interdisciplinary fields, with additional opportunities for minor concentrations and individualized programs.[...]

    Corey Powell, Executive Editor, Discover magazine, 7-19-07



    Corey Powell is the Executive Editor at Discover magazine, where he oversees the magazine’s overall design and content, with a special emphasis on narrative features and investigative stories. He also work closely with the magazine’s new columnists, including Jaron Lanier, Bruno Maddox, and Douglas Rushkoff. Previously Mr. Powell spent eight years at Discover in other roles, including Web director, news editor, and features editor.

    Mr. Powell started his scientific career at NASA’s Goddard Space Flight Center, helping to build and test gamma-ray telescopes, before joining the editorial staff of Physics Today. He spent eight years on the Board of Editors at Scientific American, first as a features editor, then as a reviews and special projects editor, and finally as the director of the magazine’s Web site. Mr. Powell’s first book, God in the Equation - an exploration of the spiritual impulse in modern cosmology - was published in 2002 by the Free Press. He is an adjunct professor of science writing in NYU’s Science and Environmental Reporting Program (currently on sabbatical).

    Mr. Powell’s writing has appeared in The New York Times, San Francisco Chronicle, Newsday, Los Angeles Times, World Art, and The Forward. Major media appearances include guest spots on CNN, MSNBC, ABC News, Fox News, CBS News, WABC, the Sci Fi Channel, Science Friday, and BBC Radio.

    Discover magazine, launched in 1980, delivers entertaining, relevant and thought-provoking science content that feeds the mind and fuels the imagination.

    Christer Ström, Director, MAQUET Critical Care, 7-19-07



    Christer Ström is Director of the Ventilator Program at MAQUET Critical Care in Solna, Sweden. He is currently heading up the SERVO-i with NAVA launch.

    Christer has worked with intensive care and anesthesia since 1977. He started his career as a registered nurse, registered nurse anesthetist, and lecturer in clinical physiology and anesthesia at Piteå Hospital in Sweden.

    Christer joined Siemens as Product Manager in 1986 and stayed with the company as a Regional Sales Manager, He was a member of the Clinical Engineering Group and Clinical Specialist for the development of the SERVO-i ventilator until GETINGE AB acquired Siemens Life Support Systems in 2003.

    MAQUET Critical Care brings together innovative medical technology, knowledge and services to help critical care providers achieve tangible, sustainable patient outcomes. With the SERVO product range, MAQUET Critical Care is the global market leader in ventilation.

    The MAQUET Group is the world market leader for Medical Systems, focused on the Operating Room and Intensive Care Unit. The integrated products of MAQUET are designed to deliver the best medical treatment within acute care hospitals. MAQUET provides innovative medical solutions from three divisions - Cardiopulmonary, Critical Care, and Surgical Workplaces.

    MAQUET is part of the publicly listed Swedish group of companies GETINGE AB, a 1.7 million euros (fiscal year 2006) turnover company with 10,100 employees worldwide. MAQUET itself is a 600 million euros (fiscal year 2006) turnover business with 2,984 Employees and 30 international sales and service subsidiaries.

    Dr. Francis Barany, Professor in the Department of Microbiology and Program of Biochemistry and Structural Biology, Cornell/Sloan Kettering Institute, 7-12-07



    Dr. Francis Barany received his Ph.D. in Microbiology in 1981 at The Rockefeller University with Professor Alexander Tomasz. He was a Helen Hay Whitney postdoctoral fellow with Professor Hamilton O. Smith at the Johns Hopkins University School of Medicine from 1982-1985. Upon appointment as an Assistant Professor in Microbiology at Weill Medical College of Cornell University in 1985, he was named a Cornell Scholar in Biomedical Sciences, and in 1992 received a five year Hirschl/Monique Weill-Caulier Career Scientist Award.

    Dr. Barany currently holds the rank of Full Professor in the Department of Microbiology and Program of Biochemistry and Structural Biology at Cornell/Sloan Kettering Institute. He has an adjunct appointment at The Rockefeller University in the Department of Chemistry, Biochemistry, and Structural Biology, as well as an appointment as Director of Mutation Research at the Strang Cancer Prevention Center. He is program director of two multi-center NCI and NIAID grants to develop new methods of cancer and infectious disease detection. He is best known for developing the ligase chain reaction (LCR) and ligase detection reaction (LDR) and Universal DNA arrays for detection of genetic diseases and cancer-associated mutations.

    Dr. Barany was named to the "SCIENTIFIC AMERICAN 50" in 2004. Dr. Barany is recognized for his outstanding achievements in the development of a universal array genomic chip, used for the rapid and accurate detection of cancers and other diseases, especially breast and colon cancer.

    Dr. Gerald Wheeler, Executive Director, National Science Teachers Association, 7-12-07



    As the Executive Director of the National Science Teachers Association (NSTA), Dr. Gerald Wheeler heads the world's largest professional organization representing science educators of all grade levels.

    Prior to joining NSTA, Dr. Wheeler was Director of the Science/Math Resource Center and Professor of Physics at Montana State University. He also headed the Public Understanding of Science and Technology Division at the American Association for the Advancement of Science (AAAS) and has served as President of the American Association of Physics Teachers (AAPT).

    Dr. Wheeler received an undergraduate degree in science education from Boston University and a Master's degree in physics and a Ph.D. in experimental nuclear physics, both from the State University of New York at Stony Brook. Between undergraduate and graduate school, he taught high school physics, chemistry, and physical science.

    For much of his career Dr. Wheeler has played a key role in the development of mass media projects that showcase science for students. He was involved in the creation of 3-2-1 Contact for the Children's Television Workshop, served on advisory boards for the Voyage of the Mimi and the PBS children's series CRO, and created and hosted Sidewalk Science, a television show for young people on CBS-affiliate WCAU-TV in Philadelphia. Dr. Wheeler has co-directed the National Teachers Enhancement Network, an NSF-funded distance learning project offering science and math courses nationwide.

    Dr. Wheeler is the recipient of numerous awards for his teaching and mass media work, including outstanding teaching awards from Temple University, the University of Hartford, and Montana State University, as well as the AAPT Milliken Award. He is a fellow of the W. K. Kellogg Foundation and AAAS and has served on advisory boards and committees for the American Institute of Physics and the National Assessment of Educational Progress. Dr. Wheeler's publications include numerous books, research and education articles, and reviews.

    The National Science Teachers Association (NSTA), founded in 1944 and headquartered in Arlington, VA, is the largest organization in the world promoting excellence and innovation in science teaching and learning for all. NSTA's current membership of more than 55,000 includes science teachers, science supervisors, administrators, scientists, business and industry representatives, and others involved in science education.

    NSTA’s four award-winning journals—The Science Teacher (grades 9-12), Science Scope (6-8), Science and Children (K-5), and Journal of College Science Teaching—provide more than 100,000 teachers with proven classroom instructional techniques.